Embattled drugmaker Mylan, which on Monday announced a cheaper, generic version of the EpiPen, has been funneling cash to lawmakers who are weighing whether to launch hearings into its sky-high prices, The Post has learned.

Sen. Charles Schumer (D-NY) has landed $10,000 in combined campaign contributions from Mylan CEO Heather Bresch and the company’s political action committee, all of which came in June, according to filings with the Federal Election Commission.

The revelation came Monday as the House Committee on Oversight and Government Reform launched a probe into the drug manufacturer.

It has also asked company officials to appear for a private briefing by Sept. 6 — just six days before the paperwork is due. A congressional hearing could be next.

“While families and schools are struggling to keep up with your company’s unreasonable price increases, Mylan has profited richly from its pricing strategy,” committee Chairman Jason Chaffetz (R-Utah) and ranking member Elijah Cummings (D-Md.) seethed in a letter to Bresch.

The show of bipartisanship came just hours after Mylan announced it would roll out a generic version of the lifesaving EpiPen emergency allergy treatment for about $300, half the $600 it had been charging.

But that $300 is still a huge price hike over the $57 a shot the medicine cost in 2007, when Mylan bought the rights to the drug.

At the same time, Bresch, daughter of Sen. Joe Manchin (D-W.Va.), saw her personal earnings soar from $2.4 million to $18.9 million, a 671 percent increase, between 2007 and last year.

Bresch also sold 100,200 shares of stock in the company just before the scandal hit, earning more than $5 million.

Schumer, who is running for a fourth term this fall, was criticized for his ties to Mylan by his underdog Republican opponent, Wendy Long, on Monday.

Long claimed Schumer’s committee had received $238,000 from the pharmaceutical industry’s PACs since 2004, and $195,000 from individual drug industry donors since 1999.

“This is yet another example of how the system is rigged,” Long said.

But Schumer said he has long supported generic drug companies in their efforts to reduce prices.

With David K. Li